학술논문

Hyper-CVAD plus ofatumumab versus hyper-CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome–negative acute lymphoblastic leukemia: A propensity score analysis
Document Type
Article
Source
In: Cancer. (Cancer, 15 September 2021, 127(18):3381-3389)
Subject
Language
English
ISSN
10970142
0008543X